Trade Mark Journal No.2026/034 21 August 2026

UK00004428968 11 August 2026 (5,10)

RELIZORBNEO

International priority date claimed: 12 February 2026 (United States of America) (99650609)

Class 5: Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory diseases and disorders.
Class 10: Filters for medical purposes, namely, for processing and converting medical nutritional formula.

Alcresta Therapeutics, Inc.

Representative: Hogan Lovells Cadwalader International LLP